Table 1.
Baseline characteristics of patients with acute viral hepatitis (n = 95).
| Variable | Non-diabetic (n = 83) | Diabetic (n = 12) | P value | |
|---|---|---|---|---|
| 1 | Age (yrs) | 30.36 ± 11.05 | 49.58 ± 13.92 | <0.001 |
| 2 | Male Sex: n (%) | 63 (75.9) | 7 (58.3) | 0.196 |
| 3 | Body mass index (kg/m2) | 21.87 ± 3.20 | 25.17 ± 2.79 | 0.010 |
| 4 | Hypertension: no. (%) | 6 (7.23) | 5 (41.67) | 0.004 |
| 5 | Waist circumference (cm) | 77.82 ± 7.92 | 89.17 ± 10.59 | <0.001 |
| 6 | Triglyceride (mg/dl) median (range) | 184 (64–175) | 259 (129–420) | 0.186 |
| 7 | HDL (mg/dl) median (range) | 36 (15–49) | 38 (30–59) | 0.155 |
| 8 | Serum bilirubin (mg/dl) median (range) | 6.95 (0.4–32.6) | 6.6 (2.4–9) | 0.453 |
| 9 | AST (U/L) median (range) | 853 (24–3485) | 1446 (791–3141) | 0.032 |
| 10 | ALT (U/L) median (range) | 998.5 (26–3241) | 1276 (612–2894) | 0.079 |
| 11 | Prothrombin time Prolongation over controls (seconds) median (range) |
2 (0.4–120) | 3 (0–8) | 0.785 |
Note. Data are expressed as mean ± SD unless otherwise indicated.
All laboratory parameter values were values obtained at admission.
HDL- High density lipoprotein; AST- Aspartate transaminase; ALT- Alanine transaminase.